Galecto, Inc. Files 8-K on Security Holder Vote Matters

Ticker: DMRA · Form: 8-K · Filed: Jun 20, 2025 · CIK: 1800315

Galecto, INC. 8-K Filing Summary
FieldDetail
CompanyGalecto, INC. (DMRA)
Form Type8-K
Filed DateJun 20, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-vote, 8-k

Related Tickers: GLTO

TL;DR

Galecto (GLTO) filed an 8-K for a shareholder vote on June 18th.

AI Summary

Galecto, Inc. filed an 8-K on June 20, 2025, reporting on a submission of matters to a vote of security holders that occurred on June 18, 2025. The company, incorporated in Delaware with its principal executive offices in Boston, MA, is involved in the pharmaceutical preparations industry.

Why It Matters

This filing indicates that Galecto, Inc. held a meeting or took action requiring a vote from its security holders, which is a standard corporate governance event.

Risk Assessment

Risk Level: low — This is a routine corporate filing related to a shareholder vote, not indicating any immediate financial distress or significant operational change.

Key Players & Entities

FAQ

What specific matters were submitted for a vote of security holders?

The filing does not specify the exact matters submitted for a vote of security holders, only that such a submission occurred on June 18, 2025.

When was the Form 8-K filed with the SEC?

The Form 8-K was filed on June 20, 2025.

What is Galecto, Inc.'s Standard Industrial Classification code?

Galecto, Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.

Where are Galecto, Inc.'s principal executive offices located?

Galecto, Inc.'s principal executive offices are located at 75 State Street, Suite 100, Boston, MA 02109.

What is the company's fiscal year end?

The company's fiscal year ends on December 31st.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding Galecto, Inc. (DMRA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing